Novasign is a young Spin-off from the University of Natural Resources and Life Sciences Vienna supporting biopharma to speed up bioprocess development to significantly reduce timelines and costs during the development of new drugs and biosimilars.
R&D:Novasign develops hybrid modeling solutions that enable process engineers to better understand bioprocesses while simultaneously offering methods to describe certain unit operations much faster and comprehensive than state-of-the-art technologies
Production:We developed a proprietary Hybrid Modeling Toolbox that enables process engineers to speed up their process development efforts. The Toolbox which uses applied machine learning algorithms does not require programming or coding skills
Services:Novasign offers - Process modeling consulting to find ideal process conditions from the data we receive - Hybrid Modeling Toolbox to enable the same workflow from the consulting directly at the customer's site. - Process modeling training to build the sound foundation and knowledge directly at the customer.
Muthgasse 11/2/1. floor
1190 Wien
Vienna
Contact: Mark Duerkop (CEO)
Email: contact@novasign.at
Website